Skip to main content
Figure 2 | BMC Endocrine Disorders

Figure 2

From: Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas

Figure 2

Decreased CgA levels in patients with insulinomas after tumor resection. Figure 2 A The serum levels of CgA were significantly reduced in 16 of 17 patients with insulinomas after resection, median 64.8 ng/ml vs. 50.4 ng/ml, P = 0.003; Figure 2 B The serum levels of CgA in healthy controls and pre-/post-operative serum levels of CgA in patients with insulinomas. Individual levels are presented as dots.

Back to article page